These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19191324)
1. An in vitro model for de- and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures. Vereyken EJ; Fluitsma DM; Bolijn MJ; Dijkstra CD; Teunissen CE Glia; 2009 Sep; 57(12):1326-40. PubMed ID: 19191324 [TBL] [Abstract][Full Text] [Related]
2. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. Birgbauer E; Rao TS; Webb M J Neurosci Res; 2004 Oct; 78(2):157-66. PubMed ID: 15378614 [TBL] [Abstract][Full Text] [Related]
3. Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion model. Degaonkar MN; Khubchandhani M; Dhawan JK; Jayasundar R; Jagannathan NR NMR Biomed; 2002 Jun; 15(4):293-300. PubMed ID: 12112612 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory responses in aggregating rat brain cell cultures subjected to different demyelinating conditions. Defaux A; Zurich MG; Honegger P; Monnet-Tschudi F Brain Res; 2010 Sep; 1353():213-24. PubMed ID: 20638371 [TBL] [Abstract][Full Text] [Related]
5. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Selvaraju R; Bernasconi L; Losberger C; Graber P; Kadi L; Avellana-Adalid V; Picard-Riera N; Baron Van Evercooren A; Cirillo R; Kosco-Vilbois M; Feger G; Papoian R; Boschert U Mol Cell Neurosci; 2004 Apr; 25(4):707-21. PubMed ID: 15080898 [TBL] [Abstract][Full Text] [Related]
6. Repeated injuries dramatically affect cells of the oligodendrocyte lineage: effects of PDGF and NT-3 in vitro. Fressinaud C Glia; 2005 Mar; 49(4):555-66. PubMed ID: 15578728 [TBL] [Abstract][Full Text] [Related]
7. A functional role for EGFR signaling in myelination and remyelination. Aguirre A; Dupree JL; Mangin JM; Gallo V Nat Neurosci; 2007 Aug; 10(8):990-1002. PubMed ID: 17618276 [TBL] [Abstract][Full Text] [Related]
8. Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity. Parenti R; Cicirata F; Zappalà A; Catania A; La Delia F; Cicirata V; Tress O; Willecke K Glia; 2010 Oct; 58(13):1594-609. PubMed ID: 20578039 [TBL] [Abstract][Full Text] [Related]
9. Rolipram promotes remyelination possibly via MEK-ERK signal pathway in cuprizone-induced demyelination mouse. Sun X; Liu Y; Liu B; Xiao Z; Zhang L Exp Neurol; 2012 Oct; 237(2):304-11. PubMed ID: 22836144 [TBL] [Abstract][Full Text] [Related]
10. Glycerophosphorylcholine phosphocholine phosphodiesterase activity in cultured oligodendrocytes, astrocytes, and central nervous tissue of dysmyelinating rodent mutants. Yuan J; McCartney DG; Monge M; Espinosa de Los Monteros A; Zalc B; de Vellis J; Kanfer JN J Neurosci Res; 1992 Jan; 31(1):68-74. PubMed ID: 1319506 [TBL] [Abstract][Full Text] [Related]
11. Pivotal role of choline metabolites in remyelination. Skripuletz T; Manzel A; Gropengießer K; Schäfer N; Gudi V; Singh V; Salinas Tejedor L; Jörg S; Hammer A; Voss E; Vulinovic F; Degen D; Wolf R; Lee DH; Pul R; Moharregh-Khiabani D; Baumgärtner W; Gold R; Linker RA; Stangel M Brain; 2015 Feb; 138(Pt 2):398-413. PubMed ID: 25524711 [TBL] [Abstract][Full Text] [Related]
12. The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination. Lindner M; Trebst C; Heine S; Skripuletz T; Koutsoudaki PN; Stangel M Glia; 2008 Aug; 56(10):1104-13. PubMed ID: 18442092 [TBL] [Abstract][Full Text] [Related]
13. Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-γ plus lipopolysaccharide-induced demyelination. Defaux A; Zurich MG; Honegger P; Monnet-Tschudi F Neuroscience; 2011 Jul; 187():84-92. PubMed ID: 21549181 [TBL] [Abstract][Full Text] [Related]
15. Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice. Clarner T; Parabucki A; Beyer C; Kipp M J Neuroendocrinol; 2011 Jul; 23(7):601-11. PubMed ID: 21507085 [TBL] [Abstract][Full Text] [Related]
16. The cellular and molecular events of central nervous system remyelination. Dubois-Dalcq M; Armstrong R Bioessays; 1990 Dec; 12(12):569-76. PubMed ID: 2080911 [TBL] [Abstract][Full Text] [Related]
17. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Lindner M; Heine S; Haastert K; Garde N; Fokuhl J; Linsmeier F; Grothe C; Baumgärtner W; Stangel M Neuropathol Appl Neurobiol; 2008 Feb; 34(1):105-14. PubMed ID: 17961136 [TBL] [Abstract][Full Text] [Related]
18. Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy. Fressinaud C; Eyer J J Neurosci Res; 2014 Feb; 92(2):243-53. PubMed ID: 24327347 [TBL] [Abstract][Full Text] [Related]
19. Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages. Loughlin AJ; Copelman CA; Hall A; Armer T; Young BC; Landon DN; Cuzner ML J Neurosci Res; 1997 Feb; 47(4):384-92. PubMed ID: 9057131 [TBL] [Abstract][Full Text] [Related]
20. Sequential diffusion-weighted magnetic resonance imaging study of lysophosphatidyl choline-induced experimental demyelinating lesion: an animal model of multiple sclerosis. Degaonkar MN; Jayasundar R; Jagannathan NR J Magn Reson Imaging; 2002 Aug; 16(2):153-9. PubMed ID: 12203762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]